DK0571264T3 - Selvklæbende matrixsystem til den transdermale, langvarige afgivelse af piribedil - Google Patents

Selvklæbende matrixsystem til den transdermale, langvarige afgivelse af piribedil

Info

Publication number
DK0571264T3
DK0571264T3 DK93401262T DK93401262T DK0571264T3 DK 0571264 T3 DK0571264 T3 DK 0571264T3 DK 93401262 T DK93401262 T DK 93401262T DK 93401262 T DK93401262 T DK 93401262T DK 0571264 T3 DK0571264 T3 DK 0571264T3
Authority
DK
Denmark
Prior art keywords
piribedil
self
transdermal
long
matrix system
Prior art date
Application number
DK93401262T
Other languages
Danish (da)
English (en)
Inventor
Fran Oise Arnaud
Gerald Pichon
Alain Cuine
Isabelle Rault
Olivier Crambes
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0571264T3 publication Critical patent/DK0571264T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93401262T 1992-05-19 1993-05-18 Selvklæbende matrixsystem til den transdermale, langvarige afgivelse af piribedil DK0571264T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9206037A FR2691361B1 (fr) 1992-05-19 1992-05-19 Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.

Publications (1)

Publication Number Publication Date
DK0571264T3 true DK0571264T3 (da) 1999-08-09

Family

ID=9429912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93401262T DK0571264T3 (da) 1992-05-19 1993-05-18 Selvklæbende matrixsystem til den transdermale, langvarige afgivelse af piribedil

Country Status (11)

Country Link
EP (1) EP0571264B1 (de)
JP (1) JPH0632738A (de)
AT (1) ATE173623T1 (de)
AU (1) AU656266B2 (de)
CA (1) CA2096511A1 (de)
DE (1) DE69322201T2 (de)
DK (1) DK0571264T3 (de)
ES (1) ES2127259T3 (de)
FR (1) FR2691361B1 (de)
NZ (1) NZ247648A (de)
ZA (1) ZA933508B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (fr) * 1991-04-18 1995-05-12 Bernard Aranda Utilisation d'un medicament pour la fabrication d'un medicament destine au traitement des vessies hyperactives ou instables.
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
FR2744130B1 (fr) * 1996-01-31 1998-03-20 Atohaas Holding Cv Composition adhesive pour materiaux en (co) polymere (meth) acrylique
CN103373991A (zh) * 2013-07-12 2013-10-30 安徽安腾药业有限责任公司 高纯度、高收率制备吡贝地尔的方法
CN118743684B (zh) * 2024-06-18 2025-08-26 石家庄四药有限公司 一种吡贝地尔缓释片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
DE68917292T2 (de) * 1988-02-26 1995-02-02 Riker Laboratories Inc Transdermales estradiol als therapeutisches sytem.
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
GB9102089D0 (en) * 1991-01-31 1991-03-13 Johnson & Johnson Medical Net wound dressings

Also Published As

Publication number Publication date
DE69322201D1 (de) 1999-01-07
CA2096511A1 (fr) 1993-11-20
NZ247648A (en) 1995-01-27
DE69322201T2 (de) 1999-06-24
AU656266B2 (en) 1995-01-27
ES2127259T3 (es) 1999-04-16
FR2691361A1 (fr) 1993-11-26
JPH0632738A (ja) 1994-02-08
ATE173623T1 (de) 1998-12-15
FR2691361B1 (fr) 1994-07-08
AU3860793A (en) 1993-11-25
EP0571264A1 (de) 1993-11-24
EP0571264B1 (de) 1998-11-25
ZA933508B (en) 1993-12-10

Similar Documents

Publication Publication Date Title
DE59410306D1 (de) Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)-acrylat-Mischung
FI955215A0 (fi) Hallitusti vapauttavat oksibutyniinivalmisteet
BR9407238A (pt) Dispositivo implantável de fornecimento de droga
EP0600470A3 (de) Bipolar Membran.
ATE64091T1 (de) Tablette mit verzoegerter freisetzung.
DK0598606T3 (da) Ekstruderbare sammensætninger til topisk transdermal afgivelse af lægemidler
DE69332210D1 (de) Biologisch abbaubares, schmelzgesponnenes abgabesystem zur kontrollierten freisetzung
NL187611B (nl) Sterilisatie-hulpstuk, bestemd voor plaatsing op het naaldhoudereinde van een injectiespuit.
CA2309818A1 (en) Buffered drug formulations for transdermal electrotransport delivery
ES1033552Y (es) Jeringa automatica, presurizada y precargada.
MY109271A (en) Ozone-friendly correction fluid containing a butyl methacrylate copolymer as a film forming binder
DK15789A (da) Azolsubstituerede cycloalkanolderivater, fremgangsmaade til fremstilling deraf samt anvendelse af derivaterne som landbrugs- og havebrugsfungicider.
ES2127259T3 (es) Sistema de liberacion prolongada de piribedil.
DK0468875T3 (da) Selvklæbende matrixsystem til forlænget frigivelse af piribedil af transkutan vej
DK0508095T3 (da) Dentalmaterialer på grundlag af (meth)-acrylater
FI920074A7 (fi) Pinnoitettua vinyyliasetaatin ja eteenin sekapolymeeria olevat rakeet, menetelmä niiden valmistamiseksi ja niiden käyttö liimoina
ATE219665T1 (de) Dosisformen und deren verwendungen
DE69209228D1 (de) Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe
ES2154392T3 (es) Composiciones adhesivas termofusibles a base de copolimeros que comprenden etileno, acetato de vinilo y vinilalcoxisilano.
NO891277D0 (no) Fordeleranordning for telekommunikasjonsanlegg.
DK113388D0 (da) Laegemiddel med forsinket afgivelse af virksomt stof
NL1002937A1 (nl) Gerede infusie-set.
SU1287542A1 (ru) Сополимер n-винил-4,5,6,7-тетрагидроиндола с винилацетатом в качестве инсектицида
NO910943L (no) Delbart roer- og roerkapslingssystem.
SE9500610D0 (sv) Medel för tandvård innehållande ubikinon